The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors regorafenib

ABSTRACT: Interventions: 12 weeks /Application of aluminium chloride ointment once a day and application of wound dressing after the presentation of grade 1 hand-foot syndrome Primary outcome(s): Incidence of Grade 3 HFS Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2647838 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR